Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.
about
Intensive care for cancer patientsManagement of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French S[Neutropenia and sepsis].Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study.Patients with hematologic malignancies have many reasons to die during extracorporeal membrane oxygenationClinical outcomes and microbiological characteristics of severe pneumonia in cancer patients: a prospective cohort study.Retrospective analysis of outcome of women with breast or gynaecological cancer in the intensive care unit.Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology.Intensive care of the cancer patient: recent achievements and remaining challengesEthical and clinical aspects of intensive care unit admission in patients with hematological malignancies: guidelines of the ethics commission of the French society of hematology.Prognosis-related factors in intensive care unit (ICU) patients with hematological malignancies: A retrospective cohort analysis in a Chinese population.Personalized treatment of severe pneumonia in cancer patients.Sequential Organ Failure Assessment Score Modified for Recent Infection in Patients With Hematologic Malignant Tumors and Severe Sepsis.Short- and long-term outcomes in onco-hematological patients admitted to the intensive care unit with classic factors of poor prognosis.Current insights into severe sepsis in cancer patients.Outcome and prognostic factors of patients with acute leukemia admitted to the intensive care unit for septic shock.Acute respiratory distress syndrome in patients with hematological malignancies.Has survival increased in cancer patients admitted to the ICU? We are not sure.Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study.[Intensive medical care problems of hemato-oncological patients].[Chronic critically ill patients from the perspective of hematologists/oncologists].[Hematooncology patients in intensive care management].Early prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach.Impact of Urgent Chemotherapy in Critically Ill Patients.Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience.Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study.Early intervention on the outcomes in critically ill cancer patients admitted to intensive care units.Removal of totally implanted venous access ports for suspected infection in the intensive care unit: a multicenter observational study.
P2860
Q26749059-1B74F1DE-000C-45AA-89A1-60EF73D8C957Q27320711-F004556A-1411-40C5-A0B8-203B023A512CQ33409974-A9ADFCBF-38D1-44CE-AFA3-591A1F6DB8F0Q33709699-25F00BDC-951F-4363-A0DB-3C0D48B77B0DQ34178411-298BC1BE-EFF4-471F-AC9F-E54E3CE3EC8CQ35585423-2060BDF7-A655-4617-A322-AD48B6D9B573Q36610466-CACCBA53-8219-493F-9719-9CF0579E1127Q37805910-A74D4892-6E6E-4368-A421-EBFC7AA57D4FQ37929882-15B8CFE0-E29C-4B64-90DA-1B9332312A7FQ38263189-7B2BDE42-4671-4B15-92D4-5FA477583AEBQ38316906-D2719D8F-0DD3-44C6-AEF4-AAC98C1779ABQ38613281-515FB66D-E48F-4AF0-A7D7-CB47B52D0DAAQ40554249-0D45026E-2FA8-453A-B819-A0E3E6CF6188Q40996894-B27DB06F-B29A-4755-AB1D-08903B421CE2Q41530793-BA40BAA7-090C-4ED9-A70B-5779F40C3970Q43445240-AB4D8D3B-D308-4699-A59D-3143D9125D0AQ43910279-9D506528-D24D-432E-AF28-ECEBE7424413Q44923315-63F35ADB-6DCF-46BB-A733-174028D41278Q45105651-3A74AB05-9A6D-4849-874E-E226E2F05193Q45281444-A4946A20-3C32-4BB3-AFB1-0491E6764265Q45850212-7A743C49-1BA8-4359-93C3-C692BBF52FE5Q45962581-C5F72863-C47F-45D1-B9BC-4F403034339AQ47218273-3C04476D-2418-42C8-B213-7C4426EBC3AFQ48092940-A29C8C38-3246-4860-BF5B-01B7C5ED17C2Q49084600-B09CBACC-E236-4B07-A270-EC2F9982C081Q52845165-C4261F3C-52C9-4ABE-AC3B-5F15DC7A50CFQ53168392-473D1C40-2152-4316-9C65-43B1836DD611Q54246185-6E640B04-406F-4161-A956-6AABB09F6CD0
P2860
Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Impact of recent intravenous c ...... th hematological malignancies.
@en
Impact of recent intravenous c ...... th hematological malignancies.
@nl
type
label
Impact of recent intravenous c ...... th hematological malignancies.
@en
Impact of recent intravenous c ...... th hematological malignancies.
@nl
prefLabel
Impact of recent intravenous c ...... th hematological malignancies.
@en
Impact of recent intravenous c ...... th hematological malignancies.
@nl
P2093
P1476
Impact of recent intravenous c ...... th hematological malignancies.
@en
P2093
Anna K Van Tilborgh
Dominique D Benoit
Dominique M Vandijck
Fritz C Offner
Johan M Decruyenaere
Joke Nollet
Lucien A Noens
Pieter O Depuydt
Stijn I Blot
P2860
P2888
P304
P356
10.1007/S00134-008-1002-2
P577
2008-01-24T00:00:00Z